Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7982 |
Intermediate Similarity |
NPD9288 |
Approved |
0.7982 |
Intermediate Similarity |
NPD76 |
Approved |
0.7982 |
Intermediate Similarity |
NPD9289 |
Approved |
0.7982 |
Intermediate Similarity |
NPD9292 |
Approved |
0.7647 |
Intermediate Similarity |
NPD579 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD237 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD9360 |
Approved |
0.7304 |
Intermediate Similarity |
NPD9358 |
Approved |
0.7304 |
Intermediate Similarity |
NPD9359 |
Approved |
0.7297 |
Intermediate Similarity |
NPD8836 |
Approved |
0.7232 |
Intermediate Similarity |
NPD9291 |
Approved |
0.713 |
Intermediate Similarity |
NPD8955 |
Approved |
0.713 |
Intermediate Similarity |
NPD8954 |
Approved |
0.7099 |
Intermediate Similarity |
NPD1118 |
Discontinued |
0.7054 |
Intermediate Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.6992 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD8838 |
Approved |
0.6942 |
Remote Similarity |
NPD580 |
Discontinued |
0.6935 |
Remote Similarity |
NPD78 |
Approved |
0.6935 |
Remote Similarity |
NPD9544 |
Approved |
0.6911 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.6891 |
Remote Similarity |
NPD9086 |
Approved |
0.688 |
Remote Similarity |
NPD281 |
Approved |
0.6829 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD4262 |
Discontinued |
0.6772 |
Remote Similarity |
NPD1127 |
Approved |
0.6772 |
Remote Similarity |
NPD1128 |
Approved |
0.6741 |
Remote Similarity |
NPD2179 |
Discontinued |
0.6721 |
Remote Similarity |
NPD578 |
Discontinued |
0.6641 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.6639 |
Remote Similarity |
NPD8833 |
Approved |
0.6639 |
Remote Similarity |
NPD8831 |
Approved |
0.6615 |
Remote Similarity |
NPD282 |
Approved |
0.6583 |
Remote Similarity |
NPD9373 |
Approved |
0.6562 |
Remote Similarity |
NPD1085 |
Approved |
0.6562 |
Remote Similarity |
NPD1775 |
Approved |
0.65 |
Remote Similarity |
NPD4183 |
Phase 3 |
0.65 |
Remote Similarity |
NPD4182 |
Phase 3 |
0.65 |
Remote Similarity |
NPD9375 |
Discontinued |
0.6475 |
Remote Similarity |
NPD9374 |
Approved |
0.6466 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.6466 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.6406 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.6385 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6357 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.6349 |
Remote Similarity |
NPD9290 |
Approved |
0.6336 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.632 |
Remote Similarity |
NPD9606 |
Approved |
0.6312 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.6284 |
Remote Similarity |
NPD5321 |
Phase 3 |
0.627 |
Remote Similarity |
NPD307 |
Approved |
0.627 |
Remote Similarity |
NPD9607 |
Approved |
0.622 |
Remote Similarity |
NPD9409 |
Discontinued |
0.621 |
Remote Similarity |
NPD757 |
Phase 3 |
0.6187 |
Remote Similarity |
NPD2253 |
Discontinued |
0.6186 |
Remote Similarity |
NPD340 |
Approved |
0.6186 |
Remote Similarity |
NPD341 |
Approved |
0.6176 |
Remote Similarity |
NPD535 |
Approved |
0.6165 |
Remote Similarity |
NPD248 |
Discontinued |
0.6134 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.605 |
Remote Similarity |
NPD8859 |
Approved |
0.605 |
Remote Similarity |
NPD8861 |
Approved |
0.605 |
Remote Similarity |
NPD8862 |
Approved |
0.6029 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6014 |
Remote Similarity |
NPD1730 |
Discontinued |
0.5986 |
Remote Similarity |
NPD9704 |
Approved |
0.5959 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.594 |
Remote Similarity |
NPD515 |
Phase 1 |
0.5902 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.5893 |
Remote Similarity |
NPD9103 |
Approved |
0.5893 |
Remote Similarity |
NPD9102 |
Approved |
0.5887 |
Remote Similarity |
NPD193 |
Suspended |
0.5887 |
Remote Similarity |
NPD3695 |
Approved |
0.5887 |
Remote Similarity |
NPD3696 |
Approved |
0.5827 |
Remote Similarity |
NPD1121 |
Approved |
0.5827 |
Remote Similarity |
NPD1120 |
Approved |
0.5821 |
Remote Similarity |
NPD300 |
Approved |
0.5804 |
Remote Similarity |
NPD185 |
Approved |
0.5797 |
Remote Similarity |
NPD1058 |
Discontinued |
0.5786 |
Remote Similarity |
NPD9550 |
Approved |
0.5786 |
Remote Similarity |
NPD9551 |
Approved |
0.5764 |
Remote Similarity |
NPD4240 |
Approved |
0.5745 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.5736 |
Remote Similarity |
NPD1368 |
Approved |
0.5725 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5725 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5724 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.5724 |
Remote Similarity |
NPD250 |
Approved |
0.5724 |
Remote Similarity |
NPD249 |
Approved |
0.5724 |
Remote Similarity |
NPD166 |
Approved |
0.5703 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.5693 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.5687 |
Remote Similarity |
NPD3081 |
Clinical (unspecified phase) |
0.5676 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.5646 |
Remote Similarity |
NPD195 |
Approved |
0.5646 |
Remote Similarity |
NPD186 |
Discovery |
0.5643 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.5625 |
Remote Similarity |
NPD1431 |
Approved |
0.5625 |
Remote Similarity |
NPD1430 |
Approved |
0.5616 |
Remote Similarity |
NPD171 |
Discontinued |
0.5603
|
Remote Similarity |
NPD252 |
Clinical (unspecified phase) |